Staar Surgical Posts Downbeat Q4 Results, Joins Webtoon Entertainment, Gitlab And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Arbutus Biopharma (NASDAQ:ABUS), Ascent Industries (

Company Performance - STAAR Surgical Co reported a quarterly loss of 13 cents per share, missing the analyst consensus estimate of earnings of 6 cents per share [2] - The company reported quarterly sales of $57.801 million, which fell short of the analyst consensus estimate of $75.370 million [2] - Following the disappointing financial results, STAAR Surgical shares dipped 10.2% to $16.99 in pre-market trading [2] Market Overview - U.S. stock futures were higher, with Dow futures gaining around 0.1% on Wednesday [1] - STAAR Surgical was among the stocks moving lower in pre-market trading due to its financial report [1]